CONCERT PHARMACEUTICALS
Concert Pharmaceuticals is a clinical stage biotechnology company dedicated to creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium. Concert applies its innovative precision deuterium chemistry platform to modify specific properties of validated drug molecules, yielding a rich pipeline of new chemical entities (NCEs). Concert leverages decades of pharmaceutical experience to create novel drug candidates with potential for best-in-class efficacy and safety, while greatly reducing R&D risk, time and expense.
CONCERT PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2006-01-01
Address:
Lexington, Massachusetts, United States
Country:
United States
Website Url:
http://www.concertpharma.com
Total Employee:
51+
Status:
Active
Contact:
7816745322
Email Addresses:
[email protected]
Total Funding:
271.09 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Domain Not Resolving
Similar Organizations
ACON Laboratories
ACON Laboratories is a biotechnology firm that offers medical diagnostic and healthcare products.
Adipo Therapeutic
Adipo Therapeutic is a biotechnology company that develops polymer-based nanotherapeutics.
Arima Genomics
Arima Genomics is a biotechnology company that develops solutions to drive genomics discovery.
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
CBA PHARMA
CBA Pharma manufactures, markets, licenses, and distributes drugs for medical oncology community.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Centerline Biomedical
Centerline Biomedical, a Cleveland Clinic spin-off, is developing an innovative system
Cleveland BioLabs
Cleveland BioLabs is a clinical-stage biotech developing a robust pipeline of drugs for multiple medical and defense applications.
Danakali
Danakali (ASX:DNK,LSE:DNK) is focused on the development of the Colluli Potash Project.
Dauntless Pharmaceuticals
Dauntless Pharmaceuticals is a biotechnology company that focuses on the development of drugs.
Desert Control
cleantech company that specializes in turning deserts to green land using our patented Liquid NanoClay
Fibrocell Science
Fibrocell Science is an autologous cell therapy company developing products for aesthetic, medical and scientific applications.
Gatc Canna
Gatc Canna combines telemedicine, genetic testing, AI, and doctor education to provide medically accurate cannabis recommendations.
Generate Biomedicines
Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines.
Gradian Diagnostics
Gradian Diagnostics is a biotechnology company that focuses on developing Next-Gen medical and diagnostics technologies.
Heat Biologics
Heat Biologics is a biotechnology company focused on the field of cancer immunotherapy.
Inventprise
Inventprise is a biotechnology company specializing in GMP vaccine product development.
ITeos Therapeutics
ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.
Claritas Pharmaceuticals
Claritas Pharmaceuticals is pioneering the development of a next generation of cannabinoid therapeutics.
Kite Pharma
Kite Pharma is a development-stage biotechnology company designing and developing immune-based therapies to treat cancer indications..
Lineage Cell Therapeutics
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.
Lucerno Dynamics
Lucerno Dynamics creates medical technology that helps scan human tissue and organs during medical tests.
Mistral Therapeutics
Mistral Therapeutics operates as a biotechnology company developing medicines to treat fibrosis.
Nightingale Health
Nightingale Health is a biotechnology company transforming the prevention of chronic diseases.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Prism Pharmaceuticals
Prism Pharmaceuticals is an acute care pharmaceutical company engaged in developing and commercializing cardiovascular injectable products.
Protea Biosciences
Protea Biosciences is a biotechnology company that offers a line of mass spectrometry standards and protein sample.
Provia Laboratories
Provia Laboratories provides its pharmaceutical, academic medical center
Rejuveron Life Sciences
Rejuveron Life Sciences is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies.
Reset Pharmaceuticals
Reset Pharma is a biotechnology company that focuses on the development and commercialization of novel psychedelic treatments.
Sojournix
Sojournix is a biotechnology company developing innovative medicines for women's health and endocrine disorders.
Wuhan General Group
Nutraceutical biotechnology company focused on alternative plant-based cannabinoids and psilocybin medical research
XO1
XO1 Ltd is a virtual biotechnology company formed specifically to develop ichorcumab.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
BVF Partners
BVF Partners investment in Post-IPO Equity - Concert Pharmaceuticals
RA Capital Management
RA Capital Management investment in Post-IPO Equity - Concert Pharmaceuticals
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Concert Pharmaceuticals
GlaxoSmithKline
GlaxoSmithKline investment in Venture Round - Concert Pharmaceuticals
QVT Financial
QVT Financial investment in Series C - Concert Pharmaceuticals
Skyline Ventures
Skyline Ventures investment in Series C - Concert Pharmaceuticals
Mediphase Venture Partners
Mediphase Venture Partners investment in Series C - Concert Pharmaceuticals
TVM Capital
TVM Capital investment in Series C - Concert Pharmaceuticals
Three Arch Partners
Three Arch Partners investment in Series C - Concert Pharmaceuticals
New Leaf Venture Partners
New Leaf Venture Partners investment in Series C - Concert Pharmaceuticals
Official Site Inspections
http://www.concertpharma.com Semrush global rank: 3.28 M Semrush visits lastest month: 4.99 K
Unable to get host informations!!!
More informations about "Concert Pharmaceuticals"
Concert Pharmaceuticals - Crunchbase Company …
Contact Email [email protected] Phone Number 7816745322 Concert Pharmaceuticals is a clinical-stage biotechnology company dedicated to creating new medicines through a novel scientific approach utilizing the naturally …See details»
Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the …
Jan 19, 2023 Page 4 Forward Looking Statements This communication contains express or implied forward-looking statements related to Sun Pharmaceutical Industries Ltd. (“Sun …See details»
Sun Pharma Completes Acquisition of Concert Pharmaceuticals
Sun Pharmaceutical Industries Limited SUN HOUSE, CTS No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai 400063, India Tel.: (91-22) 4324 4324 Fax.: (91-22) 4324 4343See details»
Concert Pharmaceuticals - PitchBook
Concert Pharmaceuticals General Information Description. Concert Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company aims to discover and develop small …See details»
Concert Pharmaceuticals Company Profile | Management and
Www.concertpharma.com Concert Pharmaceuticals Profile and History Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on applying its DCE Platform® …See details»
Overview, News & Similar companies - ZoomInfo.com
Mar 5, 2023 Who is Concert Pharmaceuticals. Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on applying its DCE Platform® (deuterated chemical …See details»
Sun Pharma Completes Acquisition of Concert Pharmaceuticals
Mar 6, 2023 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715 (together with its subsidiaries and/or...See details»
Sun Pharma intends to acquire Concert Pharmaceuticals to …
Jan 24, 2023 Sun Pharmaceutical Industries Limited and Concert Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement pursuant to which Sun Pharma …See details»
Sun Pharma completes acquisition of Concert Pharmaceuticals
Mar 6, 2023 Drug major Sun Pharma on Monday said it has completed the acquisition of US-based Concert Pharmaceuticals. In January, the Mumbai-based company inked a pact to …See details»
Concert Pharmaceuticals - Craft
Aug 19, 2024 Concert Pharmaceuticals has 4 employees at their 1 location and $32.58 m in annual revenue in FY 2021. See insights on Concert Pharmaceuticals including office …See details»
Company Concert Pharmaceuticals, Inc. Deutsche Boerse AG
Jun 4, 2011 Concert Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company. The Company is focused on developing CTP-543, a Janus Kinase 1 and Janus Kinase 2 (JAK …See details»
Concert joins Sun Pharma's symphony in $576M acquisition
Jan 19, 2023 Deuruxolitinib is an oral JAK1/2 inhibitor designed to treat alopecia areata, an autoimmune disease that causes hair loss and has limited treatment options.See details»
Concert Pharmaceuticals - CB Insights
Concertpharma.com. Overview & Products; Financials; People; Alternatives & Competitors; Executives 15. Board of Directors 4. Concert Pharmaceuticals Management Team15 Team …See details»
Concert Pharmaceuticals Announces $65 Million Financing
Nov 4, 2021 For additional information: Justine Koenigsberg (investors) Concert Pharmaceuticals, Inc. (781) 674-5284 [email protected] Kathryn Morris (media) The …See details»
Working at Concert Pharmaceuticals - Zippia
Mar 14, 2024 www.concertpharma.com. Organization Type. Public. CEO. Roger D. Tung Ph.d. Social Media &D risk, time and expense. Founded in 2006, Concert Pharmaceuticals is an …See details»
Concert Pharmaceuticals Reports 2021 Financial Results and …
Mar 3, 2022 Justine Koenigsberg (investors) Concert Pharmaceuticals, Inc. (781) 674-5284 [email protected] Kathryn Morris (media) The Yates Network (914) 204-6412 …See details»
Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the …
Jan 19, 2023 Sun Pharma: Investors Dr. Abhishek Sharma +91 22 4324 2929 [email protected] Media (Global) Gaurav Chugh +91 22 4324 5373 …See details»
Concert Pharmaceuticals Raises Gross Proceeds of $66.4 Million …
Jun 6, 2022 Justine E. Koenigsberg (Investors) Concert Pharmaceuticals, Inc. (781) 674-5284 [email protected] Kathryn Morris (media) The Yates Network (914) 204-6412 …See details»
Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the
Jan 19, 2023 For more information, please visit www.concertpharma.com or follow us on Twitter, Instagram or LinkedIn. ... Organization Profile. Sun Pharmaceutical Industries Ltd. Contact …See details»
Concert Pharmaceuticals Announces Sale of VX-561 Milestones to …
May 17, 2021 Justine E. Koenigsberg (Investors) Concert Pharmaceuticals, Inc. (781) 674-5284 [email protected] Kathryn Morris (media) The Yates Network (914) 204-6412 …See details»